MyOme announced the appointment of Sam Roosz and Dr. Ravi Thadhani to its Board of Directors on April 21, 20261
Sam Roosz is Co-Founder and CEO of Crescendo Health and was previously Co-Founder of Datavant, bringing expertise in health data platforms and enterprise partnerships1
Dr. Ravi Thadhani is Executive Vice President of Clinical Affairs and Chief Medical Officer at Cedars-Sinai with over 30 years of experience in academic medicine, clinical operations, and FDA regulatory strategy1
The appointments strengthen MyOme's position as it expands its AI-powered whole-genome healthcare platform across health systems, life sciences, employers, and population health networks1
MyOme is a clinical whole genome analysis company helping families understand their risk for inherited diseases, certified under CLIA and CAP1
Sources:
1. https://www.prnewswire.com/news-releases/myome-strengthens-board-with-appointment-of-two-healthcare-leaders-302748938.html